Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Becton, Dickinson and Company    BDX

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/17/2020 01/21/2020 01/22/2020 01/23/2020 01/24/2020 Date
277.08(c) 277.53(c) 278.83(c) 278.73(c) 278.25(c) Last
1 170 937 1 290 714 1 049 668 1 134 522 1 202 293 Volume
+0.08% +0.16% +0.47% -0.04% -0.17% Change
More quotes
Financials (USD)
Sales 2020 18 038 M
EBIT 2020 4 805 M
Net income 2020 2 435 M
Debt 2020 15 093 M
Yield 2020 1,26%
Sales 2021 18 995 M
EBIT 2021 5 245 M
Net income 2021 3 226 M
Debt 2021 12 610 M
Yield 2021 1,36%
P/E ratio 2020 28,1x
P/E ratio 2021 24,1x
EV / Sales2020 5,02x
EV / Sales2021 4,63x
Capitalization 75 409 M
More Financials
Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (52.4%): surgical instruments (71.6% of net sales), pharmaceutical systems... 
More about the company
Surperformance© ratings of Becton, Dickinson and Comp
Trading Rating : Investor Rating :
More Ratings
Latest news on BECTON, DICKINSON AND COMP
01/23BECTON DICKINSON AND : BD Announces Webcast of Annual Meeting of Shareholders
PR
01/17Health Executives Brace for Change In Regulation and Competition -- WSJ
DJ
01/16Health Executives Gear Up for Change at J.P. Morgan Conference
DJ
01/10BECTON DICKINSON AND : LongueVue Capital Adds Experienced Healthcare Operating P..
PR
01/09BECTON DICKINSON AND : BD Announces Live Webcast Of First Fiscal Quarter Earning..
PR
01/06BECTON, DICKINSON AND COMPANY : Report
CO
01/03BECTON DICKINSON AND : BD to Present at the 38th Annual J.P. Morgan Healthcare C..
PR
01/03BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
2019BECTON, DICKINSON AND COMPANY : Report
CO
More news
News in other languages on BECTON, DICKINSON AND COMP
2019BECTON, DICKINSON AND COMPANY : Ex-dividend day for
2019STOCK MARKET PARIS : Le CAC40 à 3% des 6000 points
2019EN DIRECT DES MARCHES : ArcelorMittal, Safran, Casino, Ipsen, Rubis, Teleperf..
2019BECTON, DICKINSON AND COMPANY : Ex-dividend day for
2019BECTON, DICKINSON AND COMPANY : Ex-dividend day for
More news
Analyst Recommendations on BECTON, DICKINSON AND COMP
More recommendations
Sector news : Medical Supplies
01/24Abbott Laboratories Gets Expanded Indication for Infinity Deep Brain Stimulat..
DJ
01/23MEDTRONIC : Gets FDA Approval to Proceed With Investigational Device Exemption T..
DJ
01/22ABBOTT LABORATORIES : Sets 2020 Guidance
DJ
01/22ABBOTT LABORATORIES : 4Q Profit, Sales Rise
DJ
01/21Intel Names New Chairman -- Update
DJ
More sector news : Medical Supplies
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 286,41  $
Last Close Price 278,25  $
Spread / Highest target 13,2%
Spread / Average Target 2,93%
Spread / Lowest Target -8,36%
EPS Revisions
Managers
NameTitle
Vincent A. Forlenza Chairman & Chief Executive Officer
Thomas E. Polen President & Chief Operating Officer
Christopher R. Reidy Chief Financial Officer, CAO & EVP-Administration
John A. DeFord Chief Technology Officer & Executive VP
William R. Sigmund Chief Medical Officer & EVP
Sector and Competitors